2,4-Diaminopyridine - CAS 461-88-1
Catalog: |
BB026092 |
Product Name: |
2,4-Diaminopyridine |
CAS: |
461-88-1 |
Synonyms: |
pyridine-2,4-diamine; pyridine-2,4-diamine |
IUPAC Name: | pyridine-2,4-diamine |
Description: | 2,4-Pyridinediamine was studies for its interaction with cholinesterase inhibitors, neostigmine (N390010) and edrophonium (E336000) as a combined treatment for the restoration of muscle contraction. Experiments have shown the doses of neostigmine and edrophonium could be halved when they were combined with a small small amount of 2,4-pyridinediamine without apparent loss of antagonistic potency. |
Molecular Weight: | 109.13 |
Molecular Formula: | C5H7N3 |
Canonical SMILES: | C1=CN=C(C=C1N)N |
InChI: | InChI=1S/C5H7N3/c6-4-1-2-8-5(7)3-4/h1-3H,(H4,6,7,8) |
InChI Key: | IFFLKGMDBKQMAH-UHFFFAOYSA-N |
Boiling Point: | 358 °C at 760 mmHg |
Density: | 1.251 g/cm3 |
LogP: | 1.40840 |
GHS Hazard Statement: | H302+H312+H332 (50%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
JP-2021080483-A | Complex | 20210304 |
JP-2021073353-A | Resin composition and polyimide resin film | 20210202 |
CN-112047491-A | Method for removing phenolic substances in phenol aqueous solution by tyrosinase-metal organic framework compound | 20200903 |
CN-111943929-A | 2, 4-diaminopyridine nitroxide catalyst and application thereof in ring opening of azlactone alcohol | 20200825 |
JP-2020183540-A | Resin composition and polyimide resin film | 20200709 |
PMID | Publication Date | Title | Journal |
22564207 | 20120524 | Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase | Journal of medicinal chemistry |
19640706 | 20090901 | Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors | Bioorganic & medicinal chemistry letters |
19644208 | 20090701 | [The influence of palladium containing new synthesized biological active substances to protein metabolism in organism] | Georgian medical news |
19231185 | 20090315 | 2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology | Bioorganic & medicinal chemistry letters |
Complexity: | 74.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 109.063997236 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 109.063997236 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 64.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS